OPTIMIZERX CORP
OPRXNASDAQTrading Snapshot
- Day Range
- $8.25 β $8.46
- 52-Week Range
- $4.54 β $22.25
- Volume
- $2.93B
- Avg Volume
- $3.03B
- Shares Outstanding
- 18.8M
- Next Earnings
- Nov 22, 2026
Fundamentals Snapshot
- Annual Revenue
- $109M
- Last Q Revenue
- $21M
- P/E Ratio
- 32.9
- P/S Ratio
- 1.5x
- EPS (TTM)
- $0.24
- Dividend Yield
- β
- Dilution (1yr)
- +5.2%
Why Investors Own OPRX
- βHigh-growth profile β revenue up +50.6% YoY with expanding US Equity exposure.
- βHealthy economics β 43% gross margin and 13% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
OPTIMIZERX CORP
OPRXAbout OPTIMIZERX CORP
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates
OPTIMIZERX CORP tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift OPRX price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
OPTIMIZERX CORP announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.